Piramal Pharma Limited (NSE:PPLPHARMA)

India · Delayed Price · Currency is INR

184.15

+4.30 (2.39%)

May 11, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Pharma	88.69B	91.51B	81.71B	70.82B	67.34B
Pharma Growth	-3.08%	11.99%	15.39%	5.16%	14.39%
Total	88.69B	91.51B	81.71B	70.82B	67.34B
Total Growth	-3.08%	11.99%	15.39%	5.16%	14.39%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
outside India	74.89B	65.08B	56.37B	53.34B
outside India Growth	15.07%	15.45%	5.69%	6.37%
India	16.62B	16.63B	14.44B	12.26B
India Growth	-0.06%	15.14%	17.86%	50.42%
Total	91.51B	81.71B	70.82B	65.59B
Total Growth	11.99%	15.39%	7.97%	12.52%

Source: S&P Global Market Intelligence.